The Hindu BusinessLine
Signals from The Hindu BusinessLine
- CDSCO targets 18-month rollout for end-to-end digital drug regulation platform
- Tata Steel Q1 profit rises 19%; approves ₹33,873 crore Neelachal expansion
- Bajaj Finance Q1 FY27 standalone profit rises 29% to ₹5,345.5 crore
- CIBIL flags slower credit-active consumer growth as India’s credit penetration nears 28%
- Zepto pauses IPO, seeks ₹1,000 crore pre-IPO round at lower valuation
- Piramal Pharma’s consumer healthcare revenue rises 15% in Q1 FY27
- India’s proposed apparel size system could cut online returns and simplify fit choices
- Go Fashion profit falls 26% as it consolidates smaller stores into larger EBOs
- Maharashtra FDA steps up food-safety crackdown across restaurants, clubs and school zones
- Prithvi Exchange opens Thane and Ghatkopar branches, taking network to 38
- ICICI Prudential Life launches iProtect Smart Plus with fixed 10-year cover option
- Bajaj Finance targets ₹40 lakh crore AUM by FY2036, with 300-plus AI use cases planned
- Arboreal Bioinnovations raises ₹230 crore Series A to scale functional ingredients
- EU-ABC calls for India-ASEAN coordination to curb illicit trade
- Tanishq debuts Narumugai uncut diamond collection for South India
- FSSAI suspends Dior Pharmaceuticals licence; bars products from Vatave and Neuherbs
- Hyundai India Q1 profit falls 35.1% as exports and Chennai output weaken
- Torrent Pharma Q1 revenue jumps 55% after JB Pharma acquisition; PAT rises 3.3%
- Bajaj Finance Q1 profit climbs 28% to ₹6,081 crore, beating estimates
- IMPAL posts 19% revenue growth and 10% PAT rise in Q1 FY27